276 related articles for article (PubMed ID: 38689650)
21. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.
Lunn JS; Sakowski SA; Kim B; Rosenberg AA; Feldman EL
Dev Neurobiol; 2009 Nov; 69(13):871-84. PubMed ID: 19672955
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.
Hoye ML; Koval ED; Wegener AJ; Hyman TS; Yang C; O'Brien DR; Miller RL; Cole T; Schoch KM; Shen T; Kunikata T; Richard JP; Gutmann DH; Maragakis NJ; Kordasiewicz HB; Dougherty JD; Miller TM
J Neurosci; 2017 May; 37(22):5574-5586. PubMed ID: 28416596
[TBL] [Abstract][Full Text] [Related]
23. An integrative miRNA-mRNA expression analysis identifies miRNA signatures associated with SOD1 and TARDBP patient-derived motor neurons.
Dash BP; Freischmidt A; Weishaupt JH; Hermann A
Hum Mol Genet; 2024 Apr; ():. PubMed ID: 38676626
[TBL] [Abstract][Full Text] [Related]
24. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
[TBL] [Abstract][Full Text] [Related]
25. Transcriptome-pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS.
Krach F; Batra R; Wheeler EC; Vu AQ; Wang R; Hutt K; Rabin SJ; Baughn MW; Libby RT; Diaz-Garcia S; Stauffer J; Pirie E; Saberi S; Rodriguez M; Madrigal AA; Kohl Z; Winner B; Yeo GW; Ravits J
Acta Neuropathol; 2018 Sep; 136(3):405-423. PubMed ID: 29881994
[TBL] [Abstract][Full Text] [Related]
26. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations.
Kim BW; Jeong YE; Wong M; Martin LJ
Acta Neuropathol Commun; 2020 Jan; 8(1):7. PubMed ID: 32005289
[TBL] [Abstract][Full Text] [Related]
27. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
28. Interfering with lysophosphatidic acid receptor edg2/lpa
Gento-Caro Á; Vilches-Herrando E; García-Morales V; Portillo F; Rodríguez-Bey G; González-Forero D; Moreno-López B
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1004-1018. PubMed ID: 33508894
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
30. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
31. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
[TBL] [Abstract][Full Text] [Related]
32. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice.
Chen K; Northington FJ; Martin LJ
Brain Struct Funct; 2010 Mar; 214(2-3):219-34. PubMed ID: 19888600
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
[TBL] [Abstract][Full Text] [Related]
34. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
[TBL] [Abstract][Full Text] [Related]
35. Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients.
Nakamura R; Tohnai G; Nakatochi M; Atsuta N; Watanabe H; Ito D; Katsuno M; Hirakawa A; Izumi Y; Morita M; Hirayama T; Kano O; Kanai K; Hattori N; Taniguchi A; Suzuki N; Aoki M; Iwata I; Yabe I; Shibuya K; Kuwabara S; Oda M; Hashimoto R; Aiba I; Ishihara T; Onodera O; Yamashita T; Abe K; Mizoguchi K; Shimizu T; Ikeda Y; Yokota T; Hasegawa K; Tanaka F; Nakashima K; Kaji R; Niwa JI; Doyu M; Terao C; Ikegawa S; Fujimori K; Nakamura S; Ozawa F; Morimoto S; Onodera K; Ito T; Okada Y; Okano H; Sobue G;
J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):816-824. PubMed ID: 37142397
[TBL] [Abstract][Full Text] [Related]
36. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
[TBL] [Abstract][Full Text] [Related]
37. RNA-Seq profiling of spinal cord motor neurons from a presymptomatic SOD1 ALS mouse.
Bandyopadhyay U; Cotney J; Nagy M; Oh S; Leng J; Mahajan M; Mane S; Fenton WA; Noonan JP; Horwich AL
PLoS One; 2013; 8(1):e53575. PubMed ID: 23301088
[TBL] [Abstract][Full Text] [Related]
38. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.
Martin LJ; Gertz B; Pan Y; Price AC; Molkentin JD; Chang Q
Exp Neurol; 2009 Aug; 218(2):333-46. PubMed ID: 19272377
[TBL] [Abstract][Full Text] [Related]
39. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Gento-Caro Á; Vilches-Herrando E; Portillo F; González-Forero D; Moreno-López B
Brain Pathol; 2022 May; 32(3):e13022. PubMed ID: 34585475
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1
Granatiero V; Sayles NM; Savino AM; Konrad C; Kharas MG; Kawamata H; Manfredi G
Autophagy; 2021 Dec; 17(12):4029-4042. PubMed ID: 33749521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
